4/9
08:09 am
cytk
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $108.00 price target on the stock.
Low
Report
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $108.00 price target on the stock.
4/9
05:53 am
cytk
Rating for CYTK
Low
Report
Rating for CYTK
4/9
05:53 am
cytk
Rating for CYTK
Low
Report
Rating for CYTK
3/7
02:13 pm
cytk
Rating for CYTK
Low
Report
Rating for CYTK
3/6
08:11 am
cytk
Rating for CYTK
Low
Report
Rating for CYTK
3/6
08:11 am
cytk
Rating for CYTK
Low
Report
Rating for CYTK
3/4
09:16 am
cytk
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $107.00 price target on the stock.
Medium
Report
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $107.00 price target on the stock.
3/4
08:44 am
cytk
Rating for CYTK
Medium
Report
Rating for CYTK
3/4
08:44 am
cytk
Rating for CYTK
Medium
Report
Rating for CYTK
2/28
02:29 pm
cytk
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $94.00 price target on the stock.
Low
Report
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $94.00 price target on the stock.
2/28
08:18 am
cytk
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $108.00 price target on the stock.
Medium
Report
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $108.00 price target on the stock.
2/28
05:37 am
cytk
Rating for CYTK
Medium
Report
Rating for CYTK
2/28
05:37 am
cytk
Rating for CYTK
Medium
Report
Rating for CYTK